The combination of subcutaneous daratumumab with VRd was approved in July 2024 for induction and consolidation in patients ...
From FDA actions to new standard-of-care potential, the breast cancer treatment arsenal continues to expand. This week’s news ...
“Oncology nurses are unique in that we see patients for a long time. We get to know their families. We see them through graduation, through weddings, progression of disease, recurrence,” said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results